Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Eloxx Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 38 | 47 | +9 |
| Shares | 8.64M | 16.7M | +8.03M (+92.9%) |
| Value | $28.7M | $33.2M | +$4.49M (+15.7%) |
New holders (22)
Institutions that held Eloxx Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (13)
Institutions that held Eloxx Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Nuveen Asset Management, LLC | 113,477 | $377.0K |
| California State Teachers Retirement System | 39,651 | $132.0K |
| Rhumbline Advisers | 29,764 | $99.0K |
| Dimensional Fund Advisors LP | 21,179 | $70.0K |
| Alliancebernstein L.P. | 21,100 | $70.0K |
| American International Group, Inc. | 15,530 | $52.0K |
| State Board of Administration of Florida Retirement System | 15,010 | $46.0K |
| Voya Investment Management LLC | 13,850 | $46.0K |
| Russell Investments Group, Ltd. | 7,534 | $25.0K |
| Legal & General Group Plc | 3,033 | $10.0K |
| Ameritas Investment Partners, Inc. | 2,227 | $7.00K |
| Citigroup Inc | 1,764 | $6.00K |
| Bank of Montreal | 876 | $3.00K |